Friday, December 26, 2014 Last update: 3:33 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

ProPhotonix Limited Announces Interim Results for the Half Year Ended June 30, 2014

Companies mentioned in this article: ProPhotonix Limited

SALEM, NH -- (Marketwired) -- 08/26/14 -- ProPhotonix Limited (PINKSHEETS: STKR) (AIM: PPIX) (AIM: PPIR), ProPhotonix Limited (a designer and manufacturer of LED illumination systems and laser diode modules with operations in Ireland and the U.K., today announces its unaudited interim results for the six months ended June 30, 2014.

Financial Highlights

  • Revenue increased 13% to $8.3 million (1H 2013: $7.4 million)
  • Revenue increased 11% for Laser diode modules and diodes and 15% for LED systems
  • Gross profit increased 8.0% to $3.2 million (1H 2013: $3.0 million)
  • Gross profit margin decreased to 38.5% (1H 2013: 40.4%)
  • Operating loss decreased to $0.1 million (1H 2013: loss of $1.1(1) million)
  • EBITDA of $0.1 million vs. loss of $0.9(1) million in 2013
  • Order bookings of $8.6 million (1H 2013: $8.4 million)
  • 1.03 Book-to-Bill ratio from existing and new customers
  • Percentage revenue by market sectors: industrial 74%, medical 17%, and security & defense 9%
  • Percentage revenue by geography: 49% Europe, 32% North America and 19% Rest of World
  • Cash balance of $0.3 million (June 30, 2013: $0.7 million); available credit lines of $1.8 million.

(1) Includes restructuring and non-recurring costs of $582,000

Tim Losik, President & CEO, Commented:

"During the first half 2014, the Company has experienced an improvement in business activity with order bookings through the first six months of 2014 totaling $8.6 million and the June 30, 2014 backlog of unshipped orders, $7.2 million, up 4% since December 31, 2013. The Company ended the first six months of 2014 with a book-to-bill ratio of 1.03.

"We produced significant improvements in the operating performance versus the first half 2013, excluding the 2013 restructuring charge of $582K, including: Loss from operations decreased 73%, EBITDA improved from an adjusted loss of $275,000 to a profit of $118,000, and Net loss decreased 52%. The improvement in operating performance is the result of increased revenue, product mix, cost reductions, and overhead absorption. The additional actions taken to reduce costs in the first half of 2014, as previously announced on May 22, 2014, will reduce our break-even point on a go forward basis. The combination of a reduced break-even point, increased sales activity and significant new business opportunities together with the business moving towards being cash flow positive, all indicate improved prospects for 2015.

"As stated in our annual report for 2013, customer driven product development activity continues to remain strong. We completed many of the large customer funded development initiatives that started in 2013 and expect to begin shipping production orders from these projects in late 2014 and early 2015. These potential high volume OEM (custom) applications include illuminators for the semiconductor, optical sorting, and medical markets.

"During the first half of 2014, we also began working on additional large customer driven non recurring engineering opportunities that we anticipate will result in significant production volumes in 2015 and beyond. These applications include products in the medical market and additional OEM (custom) applications in the optical inspection market. We recently announced two new products adding to our product portfolio, and we expect additional new product announcements during 2014."

About ProPhotonix

ProPhotonix Limited, headquartered in Salem, New Hampshire, is an independent designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Oclaro, Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com.

Half Year 2014 Financial Results

Revenue for the half year ended June 30 2014 was $8.3 million, an increase of 13% compared with $7.4 million in the same period of 2013. Gross profit was $3.2 million, an increase of 8% compared to $3.0 million in the first half of 2013. Gross profit margin decreased to 38.5% from 40.4% in the same period 2013 due to a shift in product mix. Foreign currency exchange impact on gross profit was negligible, however, operating income was negatively impacted by approximately $0.2 million.

Operating expenses, excluding intangible amortization charges, totaled $3.3 million versus $3.4 million in 2013 for the comparable period, excluding the one-time restructuring costs of $582K. Sales and marketing and research and development (R&D) expenses were flat in 2014 from the first half 2013 at $1.8 million, while general and administrative expenses decreased 10% over the same period, excluding the one-time restructuring charge. The operating loss was $0.1 million, as compared to a $0.5 million loss in the same period 2013, excluding the one-time restructuring charge. EBITDA was $0.1 million as compared to a loss of $0.3 million in 2013, excluding the one-time restructuring charge The net loss was $0.5 million compared to the first half 2013 net loss of $1.5 million.

Strategy and Markets

ProPhotonix consists of two business units: an LED systems manufacturing business based in Ireland (Cork), and a laser modules production and laser diode distribution division located in the United Kingdom (Hatfield Broad Oak). Company headquarters and the North American sales activities are based in Salem, New Hampshire, United States of America.

The Company is well positioned to make significant progress on its strategy to combine its expertise in two key areas of optics: LEDs and lasers. The Company intends to capitalize on increasing opportunities in this area by designing and manufacturing high value, high margin components for global manufacturers of equipment.

The Company has made significant investments in R&D, including expanding its R&D team, which now includes a full complement of optical, mechanical and electrical engineers and represents over 12% of the Company's total workforce of 91 employees. They are focused on continuing to develop proprietary products to meet clearly defined demand from our customers and the markets which we serve. In this regard, progress during the first half included a range of new laser module and LED OEM opportunities including development for new customer applications. Currently, the majority of the Company's R&D and product development activities are specifically tied to future customer requirements.


                            PROPHOTONIX LIMITED
   CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
                In thousands except share and per share data
                                (unaudited)

                                                         Six Months Ended
                                                             June 30,
                                                       --------------------
                                                          2014       2013
                                                       ---------  ---------

Revenue                                                $   8,319  $   7,365
Cost of sales                                             (5,116)    (4,393)
                                                       ---------  ---------
    Gross profit                                           3,203      2,972
                                                       ---------  ---------
Operating expenses:
Selling expenses                                          (1,343)    (1,317)
General and administrative                                (1,476)    (2,221)
Research and development                                    (465)      (473)
Amortization of intangibles                                  (61)       (60)
                                                       ---------  ---------
Total operating expenses                                  (3,345)    (4,071)
                                                       ---------  ---------
Loss from operations                                        (142)    (1,099)
Other income / (expense), net                                (91)      (393)
Interest expense                                            (149)       (95)
Amortization of debt discount and financing costs           (102)        (6)
                                                       ---------  ---------
Loss from operations before income tax provision
 (benefit)                                                  (484)    (1,593)
Income tax benefit                                             -         74
                                                       ---------  ---------
Net loss                                                    (484)    (1,519)
Other comprehensive income (loss):
  Foreign currency translation                               102        151
                                                       ---------  ---------
Total comprehensive loss                               $    (382) $  (1,368)
                                                       =========  =========

Basic and diluted net loss per share                   $   (0.01) $   (0.02)
                                                       ---------  ---------
Basic and diluted weighted average shares outstanding     83,665     76,474
                                                       ---------  ---------


                            FINANCIAL STATEMENTS
                             PROPHOTONIX LIMITED
                         CONSOLIDATED BALANCE SHEETS

                                 (unaudited)
               ($ in thousands except share and per share data)

For the Periods Ended June 30, 2014 and 2013              2014       2013
------------------------------------------------------ ---------  ---------

Assets
Current assets:
Cash and cash equivalents                              $     253  $     726
Accounts receivable, less allowances of $35 in 2014
 and $92 in 2013                                           2,648      2,361
Inventories                                                2,049      1,943
Prepaid expenses and other current assets                    198         95
                                                       ---------  ---------
  Total current assets                                     5,148      5,125
Net property, plant and equipment                            230        384
Goodwill                                                     482        460
Acquired intangible assets, net                               41        156
Other long-term assets                                       277        448
                                                       ---------  ---------
  Total assets                                         $   6,178  $   6,573
                                                       =========  =========
Liabilities and Stockholders' (Deficit) Equity
Current liabilities:
Revolving credit facility                              $   1,219  $     607
Current portion of long-term debt net of unamortized
 discount of $18 at June 30, 2014 and $15 at June 30,
 2013                                                        570          -
Capital lease obligations                                      5         10
Accounts payable                                           1,612      1,952
Accrued expenses                                             985      1,755
                                                       ---------  ---------
  Total current liabilities                                4,391      4,324
Long-term debt, unamortized discount of $17 at June
 30, 2014 and $40 at June 30, 2013                         2,310      2,442
Long-term capital lease obligation, net of current
 portion                                                       -          5
Other long-term liabilities                                  178        178
                                                       ---------  ---------
  Total liabilities                                        6,879      6,949
                                                       ---------  ---------

Stockholders' (deficit) equity:
Common stock, par value $0.001; shares authorized
 250,000,000 at June 30, 2014 and 150,000,000 at June
 30, 2013; 83,665,402 shares issued and outstanding at
 June 30, 2014 and at June 30, 2013                           84         84
Paid-in capital                                          111,417    111,209
Accumulated deficit                                     (112,158)  (112,041)
Accumulated other comprehensive income                       (44)       372
                                                       ---------  ---------
  Total stockholders' (deficit) equity                      (701)      (376)
                                                       ---------  ---------
  Total liabilities and stockholders' equity           $   6,178  $   6,573
                                                       =========  =========



                            PROPHOTONIX LIMITED
                   CONSOLIDATED STATEMENTS OF CASH FLOWS
                                In thousands
                                (unaudited)

                                                         Six Months Ended
                                                             June 30,
                                                       --------------------
                                                          2014       2013
                                                       ---------  ---------
Operations
Net loss                                               $    (484) $  (1,519)

Adjustments to reconcile net loss to net cash used in
 operating activities:
  Stock based compensation                                   114         75
  Depreciation and amortization                              146        167
  Foreign exchange gain                                       88        154
  Amortization of debt discount and financing costs           95          6
  Loss on disposal of assets                                   4         12
  Deferred taxes                                               -        (74)
  Provision for inventories                                   48         77
  Provision for bad debts                                     22         62
Other change in assets and liabilities:
  Accounts receivable                                       (132)      (235)
  Inventories                                               (111)       (17)
  Prepaid expenses and other current assets                   22        138
  Accounts payable                                            82        (23)
  Accrued expenses                                          (313)       685
                                                       ---------  ---------
Net cash used in operating activities                       (419)      (492)

Financing
Net borrowing of revolving credit facility                   101        (44)
Proceeds from long-term debt issuance                        175        640
Principal repayment of long-term debt                         (4)      (310)
Debt issuance costs                                            -       (358)
                                                       ---------  ---------

Net cash used in financing activities                        272        (72)

Investing
Purchase of plant and equipment                              (18)        (9)
                                                       ---------  ---------
Net cash used in investing activities                        (18)        (9)
Effect of exchange rate on cash                               16         21
                                                       ---------  ---------
  Net change in cash and equivalents                        (149)      (552)
Cash and equivalents, beginning of period                    402      1,278
                                                       ---------  ---------
  Cash and equivalents, end of period                  $     253  $     726
                                                       =========  =========
Supplemental disclosure of cash flow information:
Cash paid for interest                                 $     149  $      70
Common stock issued in connection with financing       $       -  $     193
Warrants issued in connection with financing           $       -  $      55


                            PROPHOTONIX LIMITED
        CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY / (DEFICIT)

                               (in thousands)

            Common Stock
           -------------
                                                Accumulated       Total
                                                   Other      Stockholders'
                    Par   Paid in Accumulated  Comprehensive      Equity
           Shares $0.001  Capital   Deficit        Income       (Deficit)
           ------ ------ -------- -----------  -------------  -------------

Balance
 December
 31, 2013  83,665 $   84 $111,302 $  (111,674) $        (146) $        (434)
Net loss                                 (484)                         (484)
Translation
 adjustment                                              102            102
Share
 based
 compen-
 sation         -      -      114           -              -            114
           ------ ------ -------- -----------  -------------  -------------
Balance
 June 30,
 2014      83,665 $   84 $111,417 $  (112,158) $         (44) $        (701)
           ====== ====== ======== ===========  =============  =============

Values may not add due to rounding

Notes to unaudited Interim Results

Basis of Presentation

The Company financial reports are issued under the recognition and measurement principles of United States Generally Accepted Accounting Principles (GAAP). The Accompanying unaudited condensed consolidated financial reports reflect all adjustments of a normal recurring nature necessary for a fair statement of the (i) results of operations and comprehensive income (loss) for the six month periods ended June 30, 2014 and 2013; (ii) the financial position at June 30, 2014 and June 30, 2013; and (iii) the cash flows for the six month period ended June 30, 2014 and 2013. These interim results are not necessarily indicative of results for a full year or any other interim period.

Cautionary Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact, including without limitation, those with respect to ProPhotonix's goals, plans and strategies set forth herein are forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: uncertainty that cash balances may not be sufficient to allow ProPhotonix to meet all of its business goals; uncertainty that ProPhotonix's new products will gain market acceptance; the risk that delays and unanticipated expenses in developing new products could delay the commercial release of those products and affect revenue estimates; the risk that one of our competitors could develop and bring to market a technology that is superior to those products that we are currently developing; and ProPhotonix's ability to capitalize on its significant research and development efforts by successfully marketing those products that the Company develops. Forward-looking statements represent management's current expectations and are inherently uncertain. All Company, brand, and product names are trademarks or registered trademarks of their respective holders. ProPhotonix undertakes no duty to update any of these forward-looking statements.

Use of Non-GAAP Financial Measures

The Company provides non-GAAP financial measures, such as EBITDA, to complement its consolidated financial statements presented in accordance with GAAP. Non-GAAP financial measures do not have any standardized definition and, therefore, are unlikely to be comparable to similar measures presented by other reporting companies. These non-GAAP financial measures are intended to supplement the user's overall understanding of the Company's current financial and operating performance and its prospects for the future. Specifically, the Company believes the non-GAAP results provide useful information to both management and investors by identifying certain expenses, gains and losses that, when excluded from the GAAP results, may provide additional understanding of the Company's core operating results or business performance, which management uses to evaluate financial performance for purposes of planning for future periods. However, these non-GAAP financial measures are not intended to supersede or replace the Company's GAAP results.

The Company uses EBITDA (earnings before interest, taxes, depreciation, amortization, stock-based compensation and impairment charges) as a non-GAAP financial measure in this press release. A reconciliation of net loss to EBITDA for the six months ended June 30, 2014 and 2013 is as follows:


                                                           (in thousands)
                                                          Six Months Ended
                                                              June 30,
                                                           2014      2013
                                                         --------  --------
Net Loss                                                     (484)   (1,519)
Plus:
  Interest and other expense, net                             240       488
  Amortization of debt discount and financing costs           102         6
  Depreciation                                                 85       107
  Intangible asset amortization                                61        60
  Stock based compensation                                    114        75
  Tax benefit                                                   -       (74)

                                                         --------  --------
EBITDA gain (loss)                                            118      (857)

  Restructuring and nonrecurring charges                        -       582
                                                         --------  --------
Adjusted EBITDA gain (loss)                                   118      (275)


Contact:

Contact:

ProPhotonix Limited
Tim Losik
President & CEO
Tel: +1 603 870 8220
ir@prophotonix.com

N+1 Singer
Andrew Craig/ Ben Wright
Tel: +44 (0)207 496 3000